title: ["PEG dilemma" for liposomes and its solving approaches].
abstract: Polyethylene glycol (PEG) is extensively used to increasing the in vivo and in vitro stability of liposomes. However, PEGylated liposomes also produce some negative effects with further research, such as low cellular uptake, poor "endosomal escape" of pH sensitive liposome (PSL) and accelerated blood clearance (ABC) phenomenon, and this situation is referred as the "PEG dilemma". "PEG dilemma" posed severe challenges for the targeted delivery of PEGylated liposomes-loaded anticancer drugs, effective intracellular release of PEGylated PSL-encapsulated gene and protein drugs, and repeated administration of PEGylated liposomes. Therefore, it is urgent to solve the "PEG dilemma". This review focused on the definition, classification of "PEG dilemma", and discussed several possible approaches to overcome "PEG dilemma".
authors.forename: Di
authors.initials: D
authors.lastname: Zhang
authors.forename: Huan
authors.initials: H
authors.lastname: Xu
authors.forename: Mei-na
authors.initials: MN
authors.lastname: Hu
authors.forename: Yi-hui
authors.initials: YH
authors.lastname: Deng
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D008081:Liposomes / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes; D011092:Polyethylene Glycols